These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 16392807)

  • 41. Synthesis and intramolecular and interionic structural characterization of half-sandwich (arene)ruthenium(II) derivatives of bis(pyrazolyl)alkanes.
    Marchetti F; Pettinari C; Pettinari R; Cerquetella A; Di Nicola C; Macchioni A; Zuccaccia D; Monari M; Piccinelli F
    Inorg Chem; 2008 Dec; 47(24):11593-603. PubMed ID: 18998632
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Palladium and platinum 3,5-diacetyl-1,2,4-triazol bis(thiosemicarbazones): chemistry, cytotoxic activity and structure-activity relationships.
    Matesanz AI; Souza P
    J Inorg Biochem; 2007 Feb; 101(2):245-53. PubMed ID: 17097146
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Ligand effects on the binding of cis- and trans-[PtCl(2)Am(1)Am(2)] to proteins.
    Najajreh Y; Peleg-Shulman T; Moshel O; Farrell N; Gibson D
    J Biol Inorg Chem; 2003 Jan; 8(1-2):167-75. PubMed ID: 12459912
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Structure and dynamics of methyl cis-3,4-diamino-2,3,4,6-tetradeoxy-alpha-L-lyxo-hexopyranoside complexes with PtCl(2) and PdCl(2), by (1)H, (2)H, (13)C, (15)N and (195)Pt NMR spectroscopy in DMSO, CD(3)CN and H(2)O.
    Bednarek E; Sitkowski J; Kawecki R; Kozerski L; Bocian W; Pazderski L; Priebe W
    Dalton Trans; 2008 Aug; (31):4129-37. PubMed ID: 18688431
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Synthesis, cytotoxicity and DNA-binding levels of ammine/propylamine platinum(II) complexes with carboxylates.
    Zhang J; Zhao X
    Eur J Med Chem; 2007 Feb; 42(2):286-91. PubMed ID: 17084487
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Role of the ancillary ligands on the stabilization of the imino-oxo tautomer of 1-methylcytosine in Pt(II) complexes.
    Longato B; Montagner D; Zangrando E
    Dalton Trans; 2009 Apr; (13):2400-5. PubMed ID: 19290374
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Structure-activity relationship of new trans-platinum(II) and (IV) complexes with cyclohexylamine. Interference with cell cycle progression and induction of cell death.
    González-Vadillo AM; Alvarez-Valdés A; Moneo V; Blanco F; Díaz RG; Carnero A; Navarro-Ranninger C
    J Inorg Biochem; 2007 Apr; 101(4):551-8. PubMed ID: 17257684
    [TBL] [Abstract][Full Text] [Related]  

  • 48. 2-(4-(Tetrahydro-2H-pyran-2-yloxy)-undecyl)-propane-1,3-diamminedichloroplatinum(II): a novel platinum compound that overcomes cisplatin resistance and induces apoptosis by mechanisms different from that of cisplatin.
    Dietrich A; Mueller T; Paschke R; Kalinowski B; Behlendorf T; Reipsch F; Fruehauf A; Schmoll HJ; Kloft C; Voigt W
    J Med Chem; 2008 Sep; 51(17):5413-22. PubMed ID: 18698754
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Reaction of Zn7metallothionein with cis- and trans-[Pt(N-donor)2Cl2] anticancer complexes: trans-Pt(II) complexes retain their N-donor ligands.
    Knipp M; Karotki AV; Chesnov S; Natile G; Sadler PJ; Brabec V; Vasák M
    J Med Chem; 2007 Aug; 50(17):4075-86. PubMed ID: 17665893
    [TBL] [Abstract][Full Text] [Related]  

  • 50. In vitro evaluation of dichloro-bis(pyrazole)palladium(II) and dichloro-bis(pyrazole)platinum(II) complexes as anticancer agents.
    Keter FK; Kanyanda S; Lyantagaye SS; Darkwa J; Rees DJ; Meyer M
    Cancer Chemother Pharmacol; 2008 Dec; 63(1):127-38. PubMed ID: 18350297
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Preparation, properties and structures of the first series of organometallic Pt(II) and Pt(IV) complexes with stibine co-ligands.
    Brown MD; Levason W; Reid G; Webster M
    Dalton Trans; 2006 Apr; (13):1667-74. PubMed ID: 16547542
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Synthesis, reactivity, spectroscopic characterization, X-ray structures, PGSE, and NOE NMR studies of (eta5-C5Me5)-rhodium and -iridium derivatives containing bis(pyrazolyl)alkane ligands.
    Pettinari C; Pettinari R; Marchetti F; Macchioni A; Zuccaccia D; Skelton BW; White AH
    Inorg Chem; 2007 Feb; 46(3):896-906. PubMed ID: 17257033
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Mixed unsymmetric oxadiazoline and/or imine platinum(II) complexes.
    Lasri J; Adília Januário Charmier M; da Silva MF; Pombeiro AJ
    Dalton Trans; 2007 Aug; (30):3259-66. PubMed ID: 17893771
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Synthesis and characterisation of mixed ligand Pt(II) and Pt(IV) oxadiazoline complexes.
    Sarju J; Arbour J; Sayer J; Rohrmoser B; Scherer W; Wagner G
    Dalton Trans; 2008 Oct; (39):5302-12. PubMed ID: 18827937
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Polyamide platinum anticancer complexes designed to target specific DNA sequences.
    Jaramillo D; Wheate NJ; Ralph SF; Howard WA; Tor Y; Aldrich-Wright JR
    Inorg Chem; 2006 Jul; 45(15):6004-13. PubMed ID: 16842007
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Spontaneous formation of heteroligated PtII complexes with chelating hemilabile ligands.
    Ulmann PA; Brown AM; Ovchinnikov MV; Mirkin CA; DiPasquale AG; Rheingold AL
    Chemistry; 2007; 13(16):4529-34. PubMed ID: 17393545
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Hard/soft selectivity in ligand substitution reactions of beta-diketonate platinum(II) complexes.
    De Pascali SA; Papadia P; Capoccia S; Marchiò L; Lanfranchi M; Ciccarese A; Fanizzi FP
    Dalton Trans; 2009 Oct; (37):7786-95. PubMed ID: 19759954
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Influence of the position of substituents in the cytotoxic activity of trans platinum complexes with hydroxymethyl pyridines.
    Martínez A; Lorenzo J; Prieto MJ; Font-Bardia M; Solans X; Avilés FX; Moreno V
    Bioorg Med Chem; 2007 Jan; 15(2):969-79. PubMed ID: 17088064
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Acetonimine and 4-imino-2-methylpentan-2-amino platinum(II) complexes: synthesis and in vitro antitumor activity.
    Ruiz J; Rodríguez V; Cutillas N; López G; Bautista D
    Inorg Chem; 2008 Nov; 47(21):10025-36. PubMed ID: 18844342
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cytotoxicity, mutagenicity, cellular uptake, DNA and glutathione interactions of lipophilic trans-platinum complexes tethered to 1-adamantylamine.
    Halámiková A; Heringová P; Kaspárková J; Intini FP; Natile G; Nemirovski A; Gibson D; Brabec V
    J Inorg Biochem; 2008; 102(5-6):1077-89. PubMed ID: 18237783
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.